AANA Answers Questions Regarding USP Chapter and Anesthesia Practice

Document Sample
AANA Answers Questions Regarding USP Chapter  and Anesthesia Practice Powered By Docstoc
					09 April NB no ads:Layout 1         3/26/09     9:42 AM     Page 9




      Like humans, dependent mice also become very sensitive to pain             that was separated by at least week, they took ondansetron in combi-
      when they stop receiving morphine.                                         nation with morphine. They were then given questionnaires to assess
          But the responses vary among the laboratory animals. There are         their withdrawal symptoms.
      “different flavors of mice,” explained Peltz. “Some strains of mice are       Similar to mice, humans treated with ondansetron before or while
      more likely to become dependent on opioids.” By comparing the with-        receiving morphine showed a significant reduction in withdrawal
      drawal symptoms and genomes of these different strains, it’s possible to   signs compared with when they received morphine but not
      figure out which genes play a major role in addiction.                     ondansetron. “A major accomplishment of this study was to take lab
          To accomplish this feat, Peltz and his colleagues used a powerful      findings and translate them to humans,” said principal investigator J.
      computational “haplotype-based” genetic mapping method that he             David Clark, MD, PhD, professor of anesthesia at Stanford University
      had recently developed, which can sample a large portion of the            School of Medicine and the Palo Alto Veterans Affairs Health Care
      genome within just a few hours. This method pinpoints genes                System.
      responsible for the variation in withdrawal symptoms across these             Chu plans on conducting a clinical study to confirm the effective-
      strains of mice.                                                           ness of another ondansetron-like drug in treating opioid withdrawal
          The analysis revealed an unambiguous result: One particular gene       symptoms in a larger group of healthy humans. And the research
      determined the severity of withdrawal. That gene codes for the 5-HT3       team will continue to test the effectiveness of ondansetron in treating
      receptor, a protein that responds to the brain-signaling chemical sero-    opioid addiction.
      tonin.
          To confirm these results, the researchers injected the dependent       Part of a Comprehensive Treatment Program
      mice with ondansetron, a drug that specifically blocks 5-HT3 recep-        The scientists warned that ondansetron will not by itself resolve the
      tors. The drug significantly reduced the jumping behavior of mice as       probl
				
DOCUMENT INFO
Description: A global leader in serving libraries of all types, ProQuest LLC (“ProQuest”) supports the breadth of the information community with innovative discovery solutions that power the business of books and the best in research experience. More than a content provider or aggregator, ProQuest is an information partner, creating indispensable research solutions that connect people and information. Through innovative, user-centered discovery technology, ProQuest offers billions of pages of global content that includes historical newspapers, dissertations, and uniquely relevant resources for researchers of any age and sophistication—including content not likely to be digitized by others.
BUY THIS DOCUMENT NOW PRICE: $6.95 100% MONEY BACK GUARANTEED
PARTNER ProQuest LLC
ProQuest creates specialized information resources and technologies that propel successful research, discovery, and lifelong learning.